The story of Viagra presents a intricate picture for those considering investment. While the initial introduction generated massive gains, the lapse of its exclusive rights opened the door to off-brand competitors, dramatically eroding revenue. This presents a unique challenge for firms relying on comparable read more blockbuster products, suggesti

The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in income, its intellectual property lapse created a deluge of lower-priced alternatives , significantly diminishing its position . While some pharmaceutical companies may seek to capitalize on related trea